It will be interesting to assess whether schizophrenia-associated mutations result in impairments in Nrg1-induced activation of p110δ-associated PI3K signaling and protein synthesis, suggesting parallels with p110β dysregulation in FXS. The gene discussed is PIK3CA; the disease is fragile X syndrome.